497 related articles for article (PubMed ID: 30718452)
21. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.
Lai SC; Su YT; Chi CC; Kuo YC; Lee KF; Wu YC; Lan PC; Yang MH; Chang TS; Huang YH
J Exp Clin Cancer Res; 2019 Nov; 38(1):474. PubMed ID: 31771617
[TBL] [Abstract][Full Text] [Related]
22. Abnormal expression and mechanism of miR-330-3p/BTG1 axis in hepatocellular carcinoma.
Zhao X; Chen GQ; Cao GM
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6888-6898. PubMed ID: 31486488
[TBL] [Abstract][Full Text] [Related]
23. Methylation-associated silencing of miR-200b facilitates human hepatocellular carcinoma progression by directly targeting BMI1.
Wu WR; Sun H; Zhang R; Yu XH; Shi XD; Zhu MS; Zeng H; Yan LX; Xu LB; Liu C
Oncotarget; 2016 Apr; 7(14):18684-93. PubMed ID: 26919246
[TBL] [Abstract][Full Text] [Related]
24. microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit.
Shi X; Liu TT; Yu XN; Balakrishnan A; Zhu HR; Guo HY; Zhang GC; Bilegsaikhan E; Sun JL; Song GQ; Weng SQ; Dong L; Ott M; Zhu JM; Shen XZ
Oncogene; 2020 Aug; 39(35):5768-5781. PubMed ID: 32719439
[TBL] [Abstract][Full Text] [Related]
25. MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma.
Wang W; Zhao LJ; Tan YX; Ren H; Qi ZT
Carcinogenesis; 2012 May; 33(5):1113-20. PubMed ID: 22362728
[TBL] [Abstract][Full Text] [Related]
26. LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR-24-3p.
Fan JC; Zeng F; Le YG; Xin L
J Cell Biochem; 2018 Aug; 119(8):6391-6397. PubMed ID: 29091305
[TBL] [Abstract][Full Text] [Related]
27. Tumor-suppressor p53 specifically binds to miR-29c-3p and reduces ADAM12 expression in hepatocellular carcinoma.
Che J; Su Z; Yang W; Xu L; Li Y; Wang H; Zhou W
Dig Liver Dis; 2023 Mar; 55(3):412-421. PubMed ID: 35853821
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA LOC107985656 represses the proliferation of hepatocellular carcinoma cells through activation of the tumor-suppressive Hippo pathway.
Zeng Y; Xu Q; Xu N
Bioengineered; 2021 Dec; 12(1):7964-7974. PubMed ID: 34565286
[TBL] [Abstract][Full Text] [Related]
29. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
Chen S; Wang L; Yao B; Liu Q; Guo C
Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
[TBL] [Abstract][Full Text] [Related]
30. A suppressive role of ionizing radiation-responsive miR-29c in the development of liver carcinoma via targeting WIP1.
Wang B; Li D; Sidler C; Rodriguez-Juarez R; Singh N; Heyns M; Ilnytskyy Y; Bronson RT; Kovalchuk O
Oncotarget; 2015 Apr; 6(12):9937-50. PubMed ID: 25888625
[TBL] [Abstract][Full Text] [Related]
31. MiR-758-3p suppresses proliferation, migration and invasion of hepatocellular carcinoma cells via targeting MDM2 and mTOR.
Jiang D; Cho WC; Li Z; Xu X; Qu Y; Jiang Z; Guo L; Xu G
Biomed Pharmacother; 2017 Dec; 96():535-544. PubMed ID: 29032337
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia-induced miR-3677-3p promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by suppressing SIRT5.
Yao B; Li Y; Niu Y; Wang L; Chen T; Guo C; Liu Q
J Cell Mol Med; 2020 Aug; 24(15):8718-8731. PubMed ID: 32596968
[TBL] [Abstract][Full Text] [Related]
34. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
Zhang N; Chen X
Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
Ma J; Li T; Han X; Yuan H
J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-26a inhibits proliferation and metastasis of human hepatocellular carcinoma by regulating DNMT3B-MEG3 axis.
Li Y; Ren M; Zhao Y; Lu X; Wang M; Hu J; Lu G; He S
Oncol Rep; 2017 Jun; 37(6):3527-3535. PubMed ID: 28440439
[TBL] [Abstract][Full Text] [Related]
37. MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma.
Guan L; Li T; Ai N; Wang W; He B; Bai Y; Yu Z; Li M; Dong S; Zhu Q; Ding XX; Zhang S; Li M; Tang G; Xia X; Zhao J; Lin S; Yao S; Zhang L; Chen G; Liu FE; Li X; Zhang H
J Exp Clin Cancer Res; 2019 Oct; 38(1):417. PubMed ID: 31623651
[TBL] [Abstract][Full Text] [Related]
38. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
[TBL] [Abstract][Full Text] [Related]
39. MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway.
Zhang JG; Shi Y; Hong DF; Song M; Huang D; Wang CY; Zhao G
Sci Rep; 2015 Jan; 5():8087. PubMed ID: 25627001
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
